Category & Conditions: Cancer
Study Phase : 2
Medicine: DAURISMO TABLETS(GLASDEGIB)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: EUCRISA™(CRISABOROLE)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: EUCRISA™(CRISABOROLE)
PrintDownloadCategory & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 2
Medicine: FRAGMIN®(DALTEPARIN SODIUM INJECTION)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: TALZENNA™(TALAZOPARIB) CAPSULES
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: VIZIMPRO® TABLETS(DACOMITINIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: XALKORI®(CRIZOTINIB)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841), ritlecitinib (PF-06651600)
PrintDownloadCategory & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: danuglipron (PF-06882961)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: Dekavil
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: fidanacogene elaparvovec (PF-06838435)
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: marstacimab (PF-06741086)
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: marstacimab (PF-06741086)
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06425090
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06425090
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: PF-06480605
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06482077
PrintDownload